BIOMARK MED 润色咨询

Biomarkers in Medicine

出版年份:2007 年文章数:1244 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:6.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2018-10-23 WWW9450

    您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢obvious 2018-10-20 发表::
    接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。
    obvious 2018-10-20 17:54:00 发表:
    三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。

    obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2022-10-14 ms6000000169610742

    版面费一般多少嘞

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2022-09-05 ms3000000824250808

    审稿速度:6.0
    经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-08-05 小破孩er

    偏重的研究方向:肿瘤
    经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2022-08-24 ms6000000169610742

    偏重的研究方向:医学检验
    经验分享:请问版面费要多少呢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-12-16 yongshuang

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向:肿瘤学;肿瘤
    经验分享:拒稿率高

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-09-29 shunyi1058

    投稿后迅速变为 Under Consideration

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2021-08-13 NANAxkj

    审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0
    偏重的研究方向:肿瘤学;临床检验
    经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2020-10-20 148a2525m13(暂无昵称)

    审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0
    偏重的研究方向:乳腺癌化疗耐药
    经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=562306, encodeId=583d562306a5, content=您好,请问审稿流程有没有under review,还是under consideration就等同于under review啊,谢谢<span class="quote">obvious 2018-10-20 发表::<br>接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span><span class="quote">obvious 2018-10-20 17:54:00 发表:<br>三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。</span>, beContent=obvious 2018-10-20 发表:: 接收率:约50% 审稿时间:约1个月 三个月接收,当时是准备投future oncology的,提前给编辑写了封信,编辑让我转投他家的这个期刊,感觉有戏就投了。一审一个月,2个审稿人,提的问题都很简单。二审两个月,二审一直是under consideration状态????,所幸等了两个月接收了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=326e2255671, createdName=WWW9450, createdTime=Tue Oct 23 00:00:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093856, encodeId=c4332093856ad, content=版面费一般多少嘞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Fri Oct 14 23:10:25 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243286, encodeId=728c124328649, content=审稿速度:6.0<br>经验分享:投稿3个月零几天了,还是under consideration,好想知道其他人一审是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abeb5679857, createdName=ms3000000824250808, createdTime=Mon Sep 05 11:55:38 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005341, encodeId=7860100534108, content=偏重的研究方向:肿瘤<br>经验分享:请问有前辈分享投稿各个状态的时间吗,7.7投稿,现在还是under consideration。这是送审了吗???, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e775436248, createdName=小破孩er, createdTime=Thu Aug 05 12:51:03 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240733, encodeId=ab921240e334b, content=偏重的研究方向:医学检验<br>经验分享:请问版面费要多少呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b96512142, createdName=ms6000000169610742, createdTime=Wed Aug 24 16:18:02 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080560, encodeId=c273108056067, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:肿瘤学;肿瘤<br>经验分享:拒稿率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16645573724, createdName=yongshuang, createdTime=Thu Dec 16 08:59:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056194, encodeId=01c7105619484, content=投稿后迅速变为 Under Consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab2452481, createdName=shunyi1058, createdTime=Wed Sep 29 18:59:25 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007656, encodeId=c278100e6567f, content=审稿速度:2.0 | 投稿命中率:95.0 | 版面费用:3500.0<br>偏重的研究方向:肿瘤学;临床检验<br>经验分享:食管癌方向偏临床的文章,审稿一个月给了个小修,修完以后一个月就直接接收了。总体来说还挺快的,版面费3500刀。需要注意的是,他们的系统在接收后没法直接看到proof的,要写编辑信才会有,编辑回信一般两天以内。投稿的时候没法选择共一和共通讯,只能在title page里体现哦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FfMe2RJZEChfmEzubib5CZw&s=100, createdBy=09725098482, createdName=NANAxkj, createdTime=Fri Aug 13 16:28:07 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893203, encodeId=ccc389320325, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0<br>偏重的研究方向:乳腺癌化疗耐药<br>经验分享:10-12投一稿,10-20收到拒稿邮件,因为做的纯生信没加湿实验,拒稿理由缺少biological validation。没有经费做实验,没办法,不知道大家有推荐的低分期刊么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9e35318435, createdName=148a2525m13(暂无昵称), createdTime=Tue Oct 20 00:26:53 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573068, encodeId=88575e3068db, content=人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eac45130515, createdName=hanbin0827_86788705, createdTime=Fri Jun 28 14:49:00 CST 2019, time=2019-06-28, status=1, ipAttribution=)]
    2019-06-28 hanbin0827_86788705

    人生第一次投稿,感觉好麻烦啊,身边的同学投稿流程就很简单,另外,我想问下通讯作者可以有几位?我再官网下载的文件中看到说是只能有一位通讯作者,可是我看到之前发过的文章有的有两位通讯作者,投稿才过了几天,是“under consideration”状态,看到大家说大概3个月接收,接收之后就是online了吗?见刊要几个月呢

    1

    展开1条回复
共56条页码: 1/6页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分